Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 6/20 | 0.44 |
| ▸ | CTSH | P09668 | 4/20 | 0.44 |
| ▸ | CTSL | P07711 | 3/20 | 0.44 |
| ▸ | CTSB | P07858 | 3/20 | 0.44 |
| ▸ | CTSS | P25774 | 3/20 | 0.44 |
| ▸ | CTSF | Q9UBX1 | 2/20 | 0.44 |
| ▸ | CTSV | O60911 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24710033 | 0.90 | CTSV (0.43) | CTSKCTSHCTSLCTSBCTSS | |
| SCHEMBL29179582 | 0.90 | CTSV (0.43) | CTSKCTSHCTSLCTSBCTSS | |
| SCHEMBL29475806 | 0.90 | CTSH (0.43) | CTSKCTSH | |
| SCHEMBL29179585 | 0.90 | CTSV (0.43) | CTSKCTSHCTSLCTSBCTSS | |
| Hydrochloric Acid SCHEMBL29179672 | 0.89 | CTSV (0.42) | CTSKCTSHCTSLCTSBCTSS | |
| Hydrochloric Acid SCHEMBL29179674 | 0.89 | CTSV (0.42) | CTSKCTSHCTSLCTSBCTSS | |
| Hydrochloric Acid SCHEMBL29179675 | 0.89 | CTSV (0.42) | CTSKCTSHCTSLCTSBCTSS | |
| SCHEMBL29475813 | 0.82 | HPGD (0.44) | CTSB | |
| SCHEMBL31644489 | 0.82 | CTSV (0.32) | CTSKCTSHCTSLCTSBCTSS | |
| SCHEMBL31644641 | 0.81 | CTSV (0.33) | CTSKCTSLCTSBCTSSCTSV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4216961-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF CORONAVIRUS INFECTION | Lighthouse Pharmaceuticals, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2022066776-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF CORONAVIRUS INFECTION | Cortexyme, Inc. (US) | 2022-03-31 | — | — | WO | disclosed |